
Clinical Study on SRS for brain metastases
📢In collaboration with @M. Carmen Rubio RodrÃguez M.D. PhD, Chief of Radiation Oncology Department, @Hospital HM Sanchinarro, Madrid, Spain, and President of the Spanish Society of Radiation Oncology, Brainlab is proud to share the promising results of a recently conducted clinical study on treating multiple brain metastases with SRS.
💡This study, conducted between May 2022 and December 2023, involved 60 patients with a total of 255 brain metastases and utilized RT Elements for treatment planning combined with ExacTrac Dynamic for patient positioning and monitoring.
The study demonstrated that excellent local control for all treated brain metastases can be achieved. Patient shifts during treatment were effectively managed, as 57% of patients and 65% of treatment fractions required repositioning based on X-ray verification. Additionally, treatments were typically completed in less than 30 minutes and administered within a single day. This provides logistical benefits for the department, enabling the treatment of a greater number of patients.
👉The evidence highlights that the single-isocenter SRS technique using Elements Multiple Brain Mets SRS combined with ExacTrac Dynamic is both feasible and accurate, offering promising clinical outcomes and logistical benefits.
Dr. Rubio is a distinguished expert in the Brainlab scientific society Novalis Circle, a global network of leading specialists in radiosurgery and radiotherapy, dedicated to fostering collaboration, knowledge exchange, as well as the development of innovative treatment techniques. Dr. Rubio and the entire radiotherapy team deserve recognition for their outstanding work. Congratulations, Dr. Rubio!
Read more about the study here: https://www.novaliscircle.org/page/item&id=6302?utm_source=LinkedIn&utm_medium=Organic+Post&utm_campaign=Clinical+Study+Carmen+Rubio+et+al.+
#medtech #radiotherapy #radiosurgery #SRS